HUSSMAN STRATEGIC ADVISORS, INC. – Halozyme Therapeutics, Inc. Transaction History
HUSSMAN STRATEGIC ADVISORS, INC. portfolio value:
$1.22M
portfolio value
HUSSMAN STRATEGIC ADVISORS, INC. quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +233.33% | 21.7K shares | 817K | $39.54 | 31K |
| Q2 2022 | share | Increase | 0.00% | 9.3K shares | 409K | $44 | 9.3K |